Skip to Content

Drug Interactions between sunitinib and Unasyn

This report displays the potential drug interactions for the following 2 drugs:

  • sunitinib
  • Unasyn (ampicillin/sulbactam)

Edit list (add/remove drugs)

Interactions between your drugs

There were no interactions found in our database between sunitinib and Unasyn - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

sunitinib

A total of 352 drugs are known to interact with sunitinib.

Unasyn

A total of 45 drugs are known to interact with Unasyn.

Drug and food interactions

Moderate

ampicillin food

Applies to: Unasyn (ampicillin / sulbactam)

You may experience reduced absorption of ampicillin in the presence of food. The effectiveness of the antibiotic may be reduced. Ampicillin should be administered one hour before or two hours after meals. This will make it easier for your body to absorb the medication. Penicillin V and amoxicillin are not affected by food and may be given without regard to meals.

Switch to professional interaction data

Moderate

SUNItinib food

Applies to: sunitinib

SUNItinib may be taken with or without food. If you are receiving therapy with SUNItinib you should avoid the regular consumption of large amounts of grapefruits and grapefruit juice. Grapefruit can raise the levels of SUNItinib in your body and lead to increased side effects. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide